Universe Pharmaceuticals (UPC) to Implement Share Consolidation

Apr 28, 2025

Key Highlights:

Universe Pharmaceuticals INC (UPC, Financial) announces a significant share consolidation.
The consolidation will transform 40 existing shares into a single share at a par value of $11.25.
No shareholder action is required, and trading will remain under the ticker "UPC".

Share Consolidation Details

Universe Pharmaceuticals INC (UPC) has announced an important financial maneuver—a share consolidation. This process will consolidate every 40 of the company's existing shares into one share, each with a par value of $11.25. The effective date for this consolidation has been set for March 24, 2025.

Purpose and Implications

This strategic move aims to streamline the firm’s share structure, enhancing its attractiveness to investors and potentially improving stock performance. Importantly, this adjustment is designed to be seamless, requiring no action from current shareholders.

Continued Trading and New CUSIP Number

Trading of Universe Pharmaceuticals will persist under the familiar ticker symbol "UPC," although the company will adopt a new CUSIP number following the consolidation. This continuity ensures a smooth transition for investors and maintains the stock’s presence in the marketplace.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.